Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Receivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueEBIATGross ProfitLeasesLong-Term Debt IssuancesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - OtherShares IssuedShares OutstandingShares Outstanding
Ratios

Dare Bioscience (DARE) Shares Outstanding (2016 - 2025)

Dare Bioscience's Shares Outstanding history spans 11 years, with the latest figure at $13.9 million for Q3 2025.

  • For Q3 2025, Shares Outstanding rose 62.99% year-over-year to $13.9 million; the TTM value through Sep 2025 reached $13.9 million, up 62.99%, while the annual FY2021 figure was $83.9 million, 101.81% up from the prior year.
  • Shares Outstanding reached $13.9 million in Q3 2025 per DARE's latest filing, up from $9.0 million in the prior quarter.
  • In the past five years, Shares Outstanding ranged from a high of $86.2 million in Q1 2023 to a low of $7.2 million in Q2 2023.
  • Average Shares Outstanding over 5 years is $42.4 million, with a median of $30.6 million recorded in 2021.
  • Peak YoY movement for Shares Outstanding: soared 127.96% in 2021, then tumbled 91.49% in 2023.
  • A 5-year view of Shares Outstanding shows it stood at $83.9 million in 2021, then grew by 1.05% to $84.8 million in 2022, then plummeted by 90.34% to $8.2 million in 2023, then grew by 4.34% to $8.5 million in 2024, then surged by 62.99% to $13.9 million in 2025.
  • Per Business Quant, the three most recent readings for DARE's Shares Outstanding are $13.9 million (Q3 2025), $9.0 million (Q2 2025), and $8.9 million (Q1 2025).